| Near-infrared photoimmunotherapy of cancer: A new approach that kills cancer cells and enhances anti-cancer host immunity H Kobayashi, A Furusawa, A Rosenberg, PL Choyke International Immunology 33 (1), 7-15, 2021 | 96 | 2021 |
| Combined CD44-and CD25-targeted near-infrared photoimmunotherapy selectively kills cancer and regulatory T cells in syngeneic mouse cancer models Y Maruoka, A Furusawa, R Okada, F Inagaki, D Fujimura, H Wakiyama, ... Cancer immunology research 8 (3), 345-355, 2020 | 56 | 2020 |
| Near infrared photoimmunotherapy; a review of targets for cancer therapy T Kato, H Wakiyama, A Furusawa, PL Choyke, H Kobayashi Cancers 13 (11), 2535, 2021 | 51 | 2021 |
| An interdigit signalling centre instructs coordinate phalanx-joint formation governed by 5′ Hoxd–Gli3 antagonism BL Huang, A Trofka, A Furusawa, JL Norrie, AH Rabinowitz, SA Vokes, ... Nature communications 7 (1), 12903, 2016 | 49 | 2016 |
| Deletion of SNAP-23 results in pre-implantation embryonic lethality in mice YH Suh, A Yoshimoto-Furusawa, KA Weih, L Tessarollo, KW Roche, ... PLoS One 6 (3), e18444, 2011 | 43 | 2011 |
| The effect of antibody fragments on CD25 targeted regulatory T cell near-infrared photoimmunotherapy R Okada, Y Maruoka, A Furusawa, F Inagaki, T Nagaya, D Fujimura, ... Bioconjugate chemistry 30 (10), 2624-2633, 2019 | 40 | 2019 |
| Local depletion of immune checkpoint ligand CTLA4 expressing cells in tumor beds enhances antitumor host immunity R Okada, T Kato, A Furusawa, F Inagaki, H Wakiyama, PL Choyke, ... Advanced therapeutics 4 (5), 2000269, 2021 | 35 | 2021 |
| Interleukin-15 after near-infrared photoimmunotherapy (NIR-PIT) enhances T cell response against syngeneic mouse tumors Y Maruoka, A Furusawa, R Okada, F Inagaki, H Wakiyama, T Kato, ... Cancers 12 (9), 2575, 2020 | 33 | 2020 |
| Eomesodermin is required for antitumor immunity mediated by 4-1BB-agonist immunotherapy C Song, K Sadashivaiah, A Furusawa, E Davila, K Tamada, A Banerjee Oncoimmunology 3 (2), e27680, 2014 | 31 | 2014 |
| Increased immunogenicity of a minimally immunogenic tumor after cancer-targeting near infrared photoimmunotherapy H Wakiyama, A Furusawa, R Okada, F Inagaki, T Kato, Y Maruoka, ... Cancers 12 (12), 3747, 2020 | 29 | 2020 |
| Near-infrared photoimmunotherapy combined with CTLA4 checkpoint blockade in syngeneic mouse cancer models Y Maruoka, A Furusawa, R Okada, F Inagaki, D Fujimura, H Wakiyama, ... Vaccines 8 (3), 528, 2020 | 27 | 2020 |
| STAT5 inhibition induces TRAIL/DR4 dependent apoptosis in peripheral T-cell lymphoma HM Simpson, A Furusawa, K Sadashivaiah, CI Civin, A Banerjee Oncotarget 9 (24), 16792, 2018 | 26 | 2018 |
| Near infrared photoimmunotherapy of cancer; possible clinical applications H Wakiyama, T Kato, A Furusawa, PL Choyke, H Kobayashi Nanophotonics 10 (12), 3135-3151, 2021 | 25 | 2021 |
| Concurrent Mutations in ATM and Genes Associated with Common γ Chain Signaling in Peripheral T Cell Lymphoma HM Simpson, RZ Khan, C Song, D Sharma, K Sadashivaiah, A Furusawa, ... PloS one 10 (11), e0141906, 2015 | 23 | 2015 |
| Near-infrared photoimmunotherapy targeting human-EGFR in a mouse tumor model simulating current and future clinical trials R Okada, A Furusawa, DW Vermeer, F Inagaki, H Wakiyama, T Kato, ... EBioMedicine 67, 2021 | 22 | 2021 |
| Treg-dominant tumor microenvironment is responsible for hyperprogressive disease after PD-1 blockade therapy H Wakiyama, T Kato, A Furusawa, R Okada, F Inagaki, H Furumoto, ... Cancer Immunology Research 10 (11), 1386-1397, 2022 | 21 | 2022 |
| Simultaneously combined cancer cell-and CTLA4-targeted NIR-PIT causes a synergistic treatment effect in syngeneic mouse models T Kato, R Okada, A Furusawa, F Inagaki, H Wakiyama, H Furumoto, ... Molecular cancer therapeutics 20 (11), 2262-2273, 2021 | 21 | 2021 |
| Electron donors rather than reactive oxygen species needed for therapeutic photochemical reaction of near-infrared photoimmunotherapy T Kato, R Okada, Y Goto, A Furusawa, F Inagaki, H Wakiyama, ... ACS pharmacology & translational science 4 (5), 1689-1701, 2021 | 21 | 2021 |
| Rapid depletion of intratumoral regulatory T cells induces synchronized Cd8 T-and nk-cell activation and ifnγ-dependent tumor vessel regression Y Kurebayashi, CP Olkowski, KC Lane, OV Vasalatiy, BC Xu, R Okada, ... Cancer research 81 (11), 3092-3104, 2021 | 20 | 2021 |
| Enhanced nanodrug delivery in tumors after near-infrared photoimmunotherapy FF Inagaki, A Furusawa, PL Choyke, H Kobayashi Nanophotonics 8 (10), 1673-1688, 2019 | 20 | 2019 |
